PBM NASDAQ
Psyence Biomedical Ltd.
1W: -2.7%
1M: +23.8%
3M: +76.8%
YTD: +575.8%
1Y: +75.1%
$5.16
-0.32 (-5.84%)
Weekly Expected Move ±11.3%
$4
$5
$5
$6
$7
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$4M
-26.8% ▼
Capital Expenditures
$10K
-72.5% ▼
Free Cash Flow
-$4M
-26.9% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$5M
+998.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| — Operating Activities — | ||||
| Net Income | -$2M | -$24K | -$51M | $1M |
| Depreciation & Amort. | $0 | $0 | $240 | $4K |
| Stock-Based Comp. | $332K | $221K | $318K | $0 |
| Change in Working Capital | $130K | -$54K | -$1M | -$386K |
| Other Non-Cash Items | $0 | -$662K | $49M | -$4M |
| Operating Cash Flow | -$1M | -$520K | -$3M | -$4M |
| — Investing Activities — | ||||
| Capital Expenditures | $0 | $0 | -$6K | -$10K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 |
| Investment Purchases | -$255M | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 |
| Other Investing | $255M | $0 | $0 | -$6K |
| Investing Cash Flow | -$32K | $0 | -$6K | -$16K |
| — Financing Activities — | ||||
| Net Debt Issuance | $0 | $0 | $2M | $7M |
| Stock Repurchased | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Financing | -$2M | $1M | $0 | $0 |
| Financing Cash Flow | -$2M | $1M | $2M | $9M |
| Net Change in Cash | -$3M | -$520K | -$601K | $5M |
| Cash End of Period | $648K | $129K | $733K | $6M |
| Free Cash Flow | -$839K | -$520K | -$3M | -$4M |